Drug intelligence / Profile preview

Jing Ceih Shern Yuan

Development stage
Phase 3
Lead developer
Chung Shan Medical University
Modality
Small Molecules
Administration
Oral
01

Overview

Jing Ceih Shern Yuan (also referred to by the code name OA1) is a Traditional Chinese Medicine (TCM) herbal formula investigated for the treatment of osteoarthritis, particularly of the knee and hip. Developed and studied by researchers at Chung Shan Medical University in Taiwan, the formula is typically administered as an extract in capsule or pill form. It is designed to alleviate joint pain and improve physical function in patients with degenerative joint diseases. Clinical evaluation, including a randomized, double-blind, placebo-controlled Phase 2/3 trial (NCT00411177), has focused on its efficacy in reducing WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) scores and its safety profile. As a multi-herb TCM product, its therapeutic effects are likely mediated through anti-inflammatory and analgesic pathways involving various phytochemical constituents.

Other names
Jing-Ceih-Shern-YuanJing Ceih Shern Yuan Extract Pill

Beyond the preview

Go deeper on Jing Ceih Shern Yuan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jing Ceih Shern Yuan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call